Trulieve Cannabis Corp. Quarterly Deferred Income Tax Expense (Benefit) in USD from Q1 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Trulieve Cannabis Corp. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2020 to Q1 2024.
  • Trulieve Cannabis Corp. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $10M.
  • Trulieve Cannabis Corp. annual Deferred Income Tax Expense (Benefit) for 2023 was -$17.2M, a 36.8% increase from 2022.
  • Trulieve Cannabis Corp. annual Deferred Income Tax Expense (Benefit) for 2022 was -$27.2M, a 3.47% decline from 2021.
  • Trulieve Cannabis Corp. annual Deferred Income Tax Expense (Benefit) for 2021 was -$26.3M, a 437% decline from 2020.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $10M +$17.9M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q1 2023 -$7.9M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2021 -$1.49M -$947K -175% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 -$540K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.